Literature DB >> 19728023

Suppressed neutrophil function in children with acute lymphoblastic leukemia.

Fumiko Tanaka1, Hiroaki Goto2, Tomoko Yokosuka2, Masakatsu Yanagimachi2, Ryosuke Kajiwara2, Takuya Naruto2, Shigeru Nishimaki2, Shumpei Yokota2.   

Abstract

Infection is a major obstacle in cancer chemotherapy. Neutropenia has been considered to be the most important risk factor for severe infection; however, other factors, such as impaired neutrophil function, may be involved in susceptibility to infection in patients undergoing chemotherapy. In this study, we analyzed neutrophil function in children with acute lymphoblastic leukemia (ALL). Whole blood samples were obtained from 16 children with ALL at diagnosis, after induction chemotherapy, and after consolidation chemotherapy. Oxidative burst and phagocytic activity of neutrophils were analyzed by flow cytometry. Oxidative burst of neutrophils was impaired in ALL patients. The percentage of neutrophils with normal oxidative burst after PMA stimulation was 59.0 +/- 13.2 or 70.0 +/- 21.0% at diagnosis or after induction chemotherapy, respectively, which was significantly lower compared with 93.8 +/- 6.1% in healthy control subjects (P = 0.00004, or 0.002, respectively); however, this value was normal after consolidation chemotherapy. No significant differences were noted in phagocytic activity in children with ALL compared with healthy control subjects. Impaired oxidative burst of neutrophils may be one risk factor for infections in children with ALL, especially in the initial periods of treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728023     DOI: 10.1007/s12185-009-0412-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  19 in total

1.  Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.

Authors:  Luciana Annino; Maria Luce Vegna; Andrea Camera; Giorgina Specchia; Giuseppe Visani; Giuseppe Fioritoni; Felicetto Ferrara; Antonio Peta; Stefania Ciolli; Wilma Deplano; Francesco Fabbiano; Simona Sica; Francesco Di Raimondo; Nicola Cascavilla; Antonio Tabilio; Pietro Leoni; Rosangela Invernizzi; Michele Baccarani; Bruno Rotoli; Sergio Amadori; Franco Mandelli
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

2.  Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI).

Authors:  D R Hargrave; I I Hann; S M Richards; F G Hill; J S Lilleyman; S Kinsey; C C Bailey; J M Chessells; C Mitchell; O B Eden
Journal:  Br J Haematol       Date:  2001-02       Impact factor: 6.998

3.  Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.

Authors:  Shuling Wu; Reinhard Gessner; Arend von Stackelberg; Renate Kirchner; Guenter Henze; Karl Seeger
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

4.  Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001.

Authors:  Merete Stubkjaer Christensen; Mats Heyman; Merja Möttönen; Bernward Zeller; Gudmundur Jonmundsson; Henrik Hasle
Journal:  Br J Haematol       Date:  2005-10       Impact factor: 6.998

5.  Ingestion and killing of bacteria by neutrophils from patients with leukemia. A new method for evaluating phagocyte function at short incubation.

Authors:  K Yamamoto; M Sasada; H Nishiyama; M Uchida; H Sawada; T Nakamura; N Maekawa; H Uchino
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1982-02

6.  Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia.

Authors:  K Hübel; K Hegener; R Schnell; G Mansmann; F Oberhäuser; P Staib; V Diehl; A Engert
Journal:  Ann Hematol       Date:  1999-02       Impact factor: 3.673

Review 7.  Infection in cancer patients. A continuing association.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1986-07-28       Impact factor: 4.965

8.  Flow cytometric determination of active oxygen (hydroperoxide) produced by peripheral blood neutrophils in patients with hematological disorders.

Authors:  H Tsurumi; M Shimazaki; T Takahashi; H Moriwaki; Y Muto
Journal:  Int J Hematol       Date:  1993-06       Impact factor: 2.490

9.  Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience.

Authors:  Jeffrey E Rubnitz; Shelly Lensing; Yinmei Zhou; John T Sandlund; Bassem I Razzouk; Raul C Ribeiro; Ching-Hon Pui
Journal:  Cancer       Date:  2004-10-01       Impact factor: 6.860

10.  Prolonged but reversible neutrophil dysfunctions differentially sensitive to granulocyte colony-stimulating factor in children with acute lymphoblastic leukaemia.

Authors:  M Lejeune; A Ferster; B Cantinieaux; E Sariban
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

View more
  3 in total

1.  Impact of neutropenia on the clinical outcomes of Staphylococcus aureus bacteremia in patients with hematologic malignancies: a 10-year experience in a tertiary care hospital.

Authors:  Byung-Han Ryu; Seung Cheol Lee; Minjeong Kim; Yewon Eom; Jiwon Jung; Min Jae Kim; Heungsup Sung; Mi-Na Kim; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jun Hee Woo; Yang Soo Kim; Yong Pil Chong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-10       Impact factor: 3.267

2.  Dynamic Changes in the Ability to Release Neutrophil ExtraCellular Traps in the Course of Childhood Acute Leukemias.

Authors:  Magdalena Ostafin; Olga Ciepiela; Michał Pruchniak; Małgorzata Wachowska; Edyta Ulińska; Piotr Mrówka; Eliza Głodkowska-Mrówka; Urszula Demkow
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

3.  Altered neutrophil immunophenotypes in childhood B‑cell precursor acute lymphoblastic leukemia.

Authors:  Elen Oliveira; Thiago S Bacelar; Juana Ciudad; Maria Cecília M Ribeiro; Daniela R N Garcia; Lukasz Sedek; Simone F Maia; Daniel B Aranha; Indyara C Machado; Arissa Ikeda; Bianca F Baglioli; Nathalia Lopez-Duarte; Lisandra A C Teixeira; Tomasz Szczepanski; Maria Luiza M Silva; Marcelo G P Land; Alberto Orfao; Elaine S Costa
Journal:  Oncotarget       Date:  2016-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.